This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Atypical Alzheimers Disease, Logopenic Variant of Primary Progressive Aphasia (LPA) or Posterior Cortical Atrophy (PCA)
and you are
over 18
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

The study is designed to assess the demographic, clinical and imaging associations with the presence of microbleeds in atypical Alzheimer's disease. The primary hypothesis is that cognitive and functional performance will be poorer in atypical Alzheimer's subjects with microbleeds compared to those without microbleeds.

Provided treatments

  • Drug: C-11 PiB

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01723553. The sponsor of the trial is Mayo Clinic and it is looking for 27 volunteers for the current phase.
Official trial title:
Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD